DE1593110A1 - Ribofuranosen und Verfahren zu deren Herstellung - Google Patents

Ribofuranosen und Verfahren zu deren Herstellung

Info

Publication number
DE1593110A1
DE1593110A1 DE19661593110 DE1593110A DE1593110A1 DE 1593110 A1 DE1593110 A1 DE 1593110A1 DE 19661593110 DE19661593110 DE 19661593110 DE 1593110 A DE1593110 A DE 1593110A DE 1593110 A1 DE1593110 A1 DE 1593110A1
Authority
DE
Germany
Prior art keywords
methyl
hours
solution
minutes
ethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19661593110
Other languages
German (de)
English (en)
Inventor
Edward Walton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of DE1593110A1 publication Critical patent/DE1593110A1/de
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H9/00Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
    • C07H9/02Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
    • C07H9/04Cyclic acetals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/08Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals directly attached to carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02Acyclic radicals, not substituted by cyclic structures
    • C07H15/04Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • C07H7/02Acyclic radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Saccharide Compounds (AREA)
DE19661593110 1965-11-15 1966-11-14 Ribofuranosen und Verfahren zu deren Herstellung Pending DE1593110A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US50769765A 1965-11-15 1965-11-15

Publications (1)

Publication Number Publication Date
DE1593110A1 true DE1593110A1 (de) 1970-07-16

Family

ID=24019753

Family Applications (2)

Application Number Title Priority Date Filing Date
DE19661768470 Pending DE1768470A1 (de) 1965-11-15 1966-11-14 1,2-O-Isopropylidin-5-O-benzoyl-3-methyl-alpha-D-ribofuranose und Verfahren zu ihrer Herstellung
DE19661593110 Pending DE1593110A1 (de) 1965-11-15 1966-11-14 Ribofuranosen und Verfahren zu deren Herstellung

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE19661768470 Pending DE1768470A1 (de) 1965-11-15 1966-11-14 1,2-O-Isopropylidin-5-O-benzoyl-3-methyl-alpha-D-ribofuranose und Verfahren zu ihrer Herstellung

Country Status (5)

Country Link
CH (1) CH490367A (OSRAM)
DE (2) DE1768470A1 (OSRAM)
FR (1) FR1498856A (OSRAM)
GB (1) GB1163102A (OSRAM)
NL (1) NL6616102A (OSRAM)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY164523A (en) 2000-05-23 2017-12-29 Univ Degli Studi Cagliari Methods and compositions for treating hepatitis c virus
CZ301182B6 (cs) 2000-05-26 2009-12-02 Idenix (Cayman) Limited Použití nukleosidových derivátu pro výrobu farmaceutických prostredku pro lécení infekcí vyvolaných flaviviry a pestiviry
EP1435974A4 (en) 2001-09-28 2006-09-06 Idenix Cayman Ltd METHODS AND COMPOSITIONS FOR THE TREATMENT OF HEPATITIS C VIRUS USING 4 'MODIFIED NUCLEOSIDES
US7608600B2 (en) 2002-06-28 2009-10-27 Idenix Pharmaceuticals, Inc. Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
AU2003263412A1 (en) * 2002-06-28 2004-01-19 Centre National De La Recherche Scientifique (Cnrs) 1'-, 2'- and 3'- modified nucleoside derivatives for treating flaviviridae infections
MXPA04012802A (es) 2002-06-28 2005-04-19 Idenix Cayman Ltd Ester 2'-c-metil-3'-o-l-valina de ribofuranosil-citidina para el tratamiento de infecciones por flaviviridae.
NZ537662A (en) 2002-06-28 2007-10-26 Idenix Cayman Ltd 2'-C-methyl-3'-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections
WO2004046331A2 (en) 2002-11-15 2004-06-03 Idenix (Cayman) Limited 2’-branched nucleosides and flaviviridae mutation
US7598373B2 (en) 2002-12-12 2009-10-06 Idenix Pharmaceuticals, Inc. Process for the production of 2-C-methyl-D-ribonolactone
JP5254033B2 (ja) 2005-12-23 2013-08-07 イデニク プハルマセウティカルス,インコーポレイテッド 分岐型ヌクレオシドを調製するための合成中間体の製造方法

Also Published As

Publication number Publication date
DE1768470A1 (de) 1971-05-13
CH490367A (de) 1970-05-15
NL6616102A (OSRAM) 1967-05-16
GB1163102A (en) 1969-09-04
FR1498856A (OSRAM) 1968-01-10

Similar Documents

Publication Publication Date Title
DE3026172A1 (de) Camptothecinderivate und ihre herstellung
DE1593110A1 (de) Ribofuranosen und Verfahren zu deren Herstellung
DE1804691C3 (de) Taurocholensäurederivate
DE1962757C3 (de) Evomonosid-Derivate, Verfahren zu deren Herstellung sowie diese enthaltende Arzneimittel
DE2125112A1 (de) Verfahren zur Herstellung von 7-Halogenlincomycinen
DE2101595A1 (de) Neue Acylderivate des Digoxins und Verfahren zu deren Herstellung
DE2738896C2 (OSRAM)
DE2614115A1 (de) Echinatin-glycoside und verfahren zu ihrer herstellung
DE2754759C2 (de) 3α-Hydroxy-5β-cholest-24-en
DE1960130A1 (de) Neue Verfahren zur Herstellung von N-(Diaethylaminoaethyl)-4-amino-5-chloro-2-methoxybenzamid
DE2331044A1 (de) Diphenylmethan-derivate und verfahren zu deren herstellung
DE2256912C2 (de) Digoxigenin-3-[2',3'-didesoxy-glykoside], Verfahren zu ihrer Herstellung und deren Verwendung
AT326638B (de) Verfahren zur herstellung von n(beta-diäthylaminoäthyl) -4-amino-5-chlor-2-methoxybenzamid
AT209007B (de) Verfahren zur Herstellung von 9 α-Halogen-4-pregnen-16 α, 17 α,21-triol-3, 11, 20-trionen und ihren Estern
EP0014478A1 (de) Verfahren zur Herstellung von Alkyl-4,10-dihydro-10-oxo-thieno-(3,2-c)-(1)-benzoxepin-8-acetat
DE890791C (de) Verfahren zur Herstellung von Dioxyacetonverbmdungen
AT239450B (de) Verfahren zur Herstellung von 16α-Alkyl-5,6-dihalogen-3β-17α-dihydroxypregnan-20-onen
DE2924334C2 (OSRAM)
DE1643226A1 (de) Photochrome Verbindungen und ihre Herstellung
DE903333C (de) Verfahren zur Herstellung von Steroid-20, 21-enolacetaten
DE907299C (de) Verfahren zur Herstellung von Chloramphenicol
DE2341062A1 (de) Neues cyclohexanpentol-derivat und verfahren zu dessen herstellung
AT234919B (de) Verfahren zur Herstellung von 6, 16α-Dialkyl-3β-hydroxy-17α, 20, 20, 21-bismethylendioxy-5-pregnen
DE960819C (de) Verfahren zur Herstellung von 11ª‰ -Oxyprogesteron
DE2226398A1 (de) Neue herzglykoside und verfahren zu ihrer herstellung